BPC:CSE, The Precision Peptide Company Inc.
Why BPC stock rose on October 29
The Precision Peptide Company Inc. rose 14.3%
on Thursday, October 29, 2026, on 635,945 shares, 5.1 times its average daily volume.
Headlines around the move:
BPC stock overview
The Precision Peptide Company Inc. (BPC:CSE) closed at $0.320 on October 29, 2026,
up 14.29% on the day.
The stock trades 44.8% below its 52-week high of $0.580
and 82.9% above its 52-week low of $0.175.
Over the past year, it lost 8.6%.
The Precision Peptide Company Inc. is part of the Diversified Industries sector.
Key figures
- Price
- $0.320
- Day change
- +14.29%
- Volume
- 635,945
- Average volume
- 124,217
- Market cap
- 17M+
- 52-week range
- $0.175 – $0.580
- 50-day average
- $0.395
- 200-day average
- $0.400
Price action over the past year
In 252 trading sessions since October 29, 2025, BPC closed higher on 97 days (38%).
Its best day was February 13, 2026 (+29.27%) and its worst was December 10, 2025 (-16.67%).
The stock moved 10% or more in a single session 24 times.
Recent signals
BPC news
-
Oct 29, 2026:
The Precision Peptide Company Quadruples U.S. Telehealth Formulary to 16 Prescription Therapies Across Seven Therapy Areas
-
Oct 28, 2026:
The Precision Peptide Company Highlights 30 Years of Peptide Science Behind Its Product Platform
-
Oct 22, 2026:
The Precision Peptide Company Locks In Exclusive Manufacturing Rights Across Its Needle-Free Line
-
Oct 20, 2026:
The Precision Peptide Company Begins Development of GLP3 Patch, Its Fourth Needle-Free Peptide
-
Oct 13, 2026:
The Precision Peptide Company Advances Needle-Free GLP-1 Tirzepatide Patch into Formal U.S. Testing
-
Oct 8, 2026:
RETRANSMISSION: The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch
-
Oct 7, 2026:
The Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch
-
Sep 29, 2026:
The Precision Peptide Company Expands U.S. Wholesale Program, Opening Distribution of Its Needle-Free Range to Clinics, Med Spas, Gyms and Retailers
About The Precision Peptide Company Inc.
Pangea Wellness Inc. is a North American manufacturer specializing in clean-label foods and innovative wellness products. Through its subsidiary Amino Innovations, the Company offers advanced, needle-free peptide therapies that support recovery, cognitive function, and overall health.
Similar stocks
Find more stocks like BPC with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.